Menu

Clinical Trials

Research

Here at IMS, we are dedicated to the advancement of medicine through our work in Research & Development.

Clinical Trials

Since 2007, IMS has been involved in clinical trials to further the medical community’s knowledge of various diseases and medications for treatment.

Therapies

In addition to traditional therapies used in gastroenterology, we are proud to be able to offer our patients access to novel therapies otherwise unavailable to the general public through the clinical trial programs we offer.

Why Us

As a Center for Therapeutic Innovation, we partner with the world’s leading physicians and pharmaceutical developers in order to provide our patients with the most cutting edge information on the most innovative therapies.

Drugs

Our team has been involved in the development of several FDA approved medications, a few of them being Xeljanz®, Harvoni®, Sovaldi®, Entyvio®, Xifaxan®, Veikira Pak®, Asacol HD® and Uceris®.

Enrollment

Below are some of the studies which are currently open for enrollment.

Get Involved!

Call or complete the form to the right to discuss your eligibility in one of our programs that are now being offered.

CURRENT STUDIES

Crohn’s Disease

CELEST (M13-740)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn’s Disease Who Have Inadequately Responded to or Are Intolerant to Anti-TNF Therapy.

Click here for more information

RECD3125         

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn’s Disease.

Click here for more information

Bergamot (GA29144)

A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn’s Disease Inhibitors.

Click here for more information

Triumph (GS-US-395-1663)

Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn’s Disease.

Click here for more information

Ulcerative Colitis

Hickory (GA28950)

A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Patients Who Are Refractory to or Intolerant of TNF Inhibitors.

Click here for more information

APD334-003

Safety and Efficacy of APD334 in Patients With Ulcerative Colitis.

Click here for more information

Triumph (GS-US-326-1100)

Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis Disease.

Click here for more information

Varsity (MLN0002-3026)

A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis.

Click here for more information

Constipation

SP304203-05

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)

Click here for more information

Hepatitis C

ENDURANCE-3 (M13-594)

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection.

Click here for more information